A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

NCT01277666 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

608

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: GSK1605786A
DRUG: GSK1605786A
DRUG: Placebo

Sponsor

GlaxoSmithKline